DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 0.00 0.00%
S&P 500 2,088.77 6.89 0.33%
market minute promo

CVS Health (NYSE: CVS)

98.25 0.36 (0.37%)

REAL-TIME: Last trade at

Extended Hours: $97.50 -$0.75 (-0.76%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

CVS $98.25 0.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.60
Previous Close $97.89
Daily Range $97.92 - $98.62
52-Week Range $64.95 - $98.62
Market Cap $112.6B
P/E Ratio 25.29
Dividend (Yield) $1.40 (1.4%)
Ex-Dividend Date
Dividend Pay Date
01/20/15
02/02/15
Volume 2,279,325
Average Daily Volume 4,413,716
Current FY EPS $4.50

Sector

Services

Industry

Retail

CVS Health (CVS) Description

The company's current operations are grouped into two businesses: Retail Pharmacy and Pharmacy Benefit Management. Website: http://www.cvshealth.com/

News & Commentary

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

3 Can't Miss Quotes from Rite Aid Corporation's CEO

Rite Aid's CEO John Standley discussed margin risk and growth opportunity during the company's fiscal third quarter earnings conference call.

Cardinal Health (CAH) Rides High on Accretive Acquisitions - Analyst Blog

Rite Aid Raises Its 2015 Outlook Backed By A Strong Q3 2015

Continued Increase In Sales Earns CVS A Bullish Thesis

Walgreen Reports A Solid Q1’15, Is Confident Of Carrying On The Growth Momentum Through Fiscal 2015

Could Express Scripts Holding Company's Gilead Gamble Backfire?

Express Scripts puts its foot down on Gilead Sciences' hepatitis C drug pricing. While the move looks like a no-brainer on the surface, could it actually come back to haunt Express Scripts?

Update: Walgreen Earnings Put The Green In Walgreen

Today's Market: Moving Higher On Strong Earnings And Pricing Power

Express Scripts Hates Gilead Sciences, Loves AbbVie

Express Scripts ditches Gilead Sciences' hepatitis C treatments from its drug formulary in favor of AbbVie.

See More CVS News...

CVS's Top Competitors

CVS $98.25 (0.37%)
Current stock: CVS
WMT $86.91 (0.56%)
Current stock: WMT
TSCDY $8.61 (0.29%)
Current stock: TSCDY
WMMVY $21.18 (1.16%)
Current stock: WMMVY